Wedbush Securities Inc Applied Genetic Technologies Corp Transaction History

Wedbush Securities Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$2.36 - $9.86 $168,716 - $704,891	-71,490 Closed	0 $0
Q4 2019 Jan 16, 2020	SELL	$2.69 - $4.92 $4,035 - $7,380	-1,500 Reduced 2.06%	71,490 $323,000
Q3 2019 Oct 17, 2019	BUY	$2.59 - $4.16 $189,044 - $303,638	72,990 New	72,990 $304,000
Q2 2018 Aug 03, 2018	SELL	$3.7 - $5.65 $37,703 - $57,573	-10,190 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$3.65 - $5.2 $37,193 - $52,988	10,190 New	10,190 $39,000
Q4 2017 Feb 09, 2018	SELL	$3.4 - $4.15 $34,646 - $42,288	-10,190 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$3.55 - $5.25 $36,174 - $53,497	10,190	10,190 $40,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.